Psoriasis affects roughly 3% of U.S. adults, which translates to about 7.55 million people. Globally, an estimated 43 million people were living with psoriasis in 2021, a number that has grown by 86% since 1990. It is one of the most common autoimmune conditions in the world, though how often it appears varies dramatically depending on where you live, your age, and your ethnic background.
Global Prevalence by Region
Psoriasis is not evenly distributed around the world. Australasia has the highest prevalence at roughly 2%, followed closely by western Europe (1.9%), central Europe (1.8%), and North America (1.5%). At the other end of the spectrum, east Asia has the lowest rates, with Taiwan reporting a prevalence as low as 0.05%. Among individual countries, Australia, Norway, Israel, and Denmark consistently rank at the top.
For years, researchers assumed psoriasis followed a latitude gradient, becoming more common the farther you move from the equator. That turns out to be an oversimplification. The pattern tracks more closely with national income than with climate. Countries in high-income regions report significantly higher prevalence than low-income countries, likely because of better access to diagnosis and medical record-keeping rather than a true biological difference.
Rates in the United States
Based on national survey data, 3.0% of American adults aged 20 and older have psoriasis. That figure is not uniform across racial and ethnic groups. Non-Hispanic White adults have the highest rate at 3.6%, followed by non-Hispanic Asian adults at 2.5%, Hispanic adults at 1.9%, and non-Hispanic Black adults at 1.5%. These differences likely reflect a combination of genetic susceptibility, diagnostic patterns, and access to care. Psoriasis in darker skin tones can look different, appearing more violet or brown rather than the classic pink-red, which sometimes leads to underdiagnosis.
When Psoriasis Typically Appears
Psoriasis can develop at any age, but onset clusters around two windows: the first between ages 20 and 30, and the second between ages 50 and 60. The earlier peak tends to run more strongly in families and is often associated with more widespread disease over a person’s lifetime.
Children get psoriasis too, though less frequently. Among kids and adolescents under 20, the prevalence rate is about 204 per 100,000, compared to 516 per 100,000 in the general population. The condition becomes more common as children age. Kids under 5 have the lowest rate (113 per 100,000), while teenagers aged 15 to 19 are nearly three times as likely to be affected (310 per 100,000). Some estimates suggest that nearly one-third of all psoriasis cases begin in childhood.
How Most Cases Break Down by Type
About 90% of people with psoriasis have plaque psoriasis, the form that produces raised, scaly patches on the elbows, knees, scalp, and lower back. The remaining 10% is split among several less common subtypes: guttate psoriasis (small, droplet-shaped spots often triggered by a strep infection), inverse psoriasis (smooth, red patches in skin folds), pustular psoriasis (pus-filled bumps), and erythrodermic psoriasis (a rare, severe form that can cover most of the body).
In terms of severity, studies that classify patients using standardized tools find that roughly 46% of cases are mild, 32% are moderate, and 20% are severe. “Mild” generally means a small percentage of skin is affected and the disease has a limited impact on daily life. “Severe” involves more extensive skin coverage, significant discomfort, and often a measurable effect on quality of life, sleep, or mental health.
The Joint Connection
Psoriasis is not just a skin disease. A large meta-analysis covering nearly one million patients found that about 1 in 5 people with psoriasis eventually develop psoriatic arthritis, a condition that causes joint pain, stiffness, and swelling. In studies that used the most current diagnostic criteria, the proportion rose to nearly 1 in 4. European and South American patients had the highest rates (around 22 to 23%), while Asian patients had somewhat lower rates (about 14%).
In children, psoriatic arthritis is far less common, affecting about 3.3% of those with skin psoriasis. Joint symptoms can appear years or even decades after the first skin patches, which is why ongoing monitoring matters for anyone with a psoriasis diagnosis. Joint damage from psoriatic arthritis is progressive, so catching it early makes a significant difference in long-term outcomes.
Why the Numbers Keep Rising
The global age-standardized prevalence of psoriasis rose from about 478 per 100,000 people in 1990 to 516 per 100,000 in 2021. The total case count jumped from roughly 23 million to 43 million over that same period. Population growth and aging explain part of this increase, since psoriasis accumulates over a lifetime (it is chronic and rarely resolves completely). But improved awareness and access to dermatological care in middle-income countries are also contributing. More people are being diagnosed who, a generation ago, would never have seen a dermatologist.